Fresenius Medical Care has successfully completed its merger with NxStage Medical, Inc.

More Info

NxStage Kidney Care Hosts Grand Opening Event at Florida Dialysis Center

LAWRENCE, Mass. – (October 8, 2014) NxStage® Kidney Care, Inc., a subsidiary of NxStage® Medical, Inc. (Nasdaq: NXTM), today announced the grand opening of the company’s South Orlando, Florida dialysis center. The new state-of-the art facility, located at 14522 Landstar Boulevard, is owned and managed in partnership with Central Florida Kidney Center, a nationally recognized dialysis provider for over 42 years. To celebrate, the center will host a ribbon cutting ceremony on November 7, 2014 from 3pm – 7pm with special guest recording artist and former NxStage® System One™ patient David RUSH.

“I believe this new NxStage Kidney Care center offers a different dialysis experience to patients,” said NxStage Kidney Care South Orlando Medical Director Dr. Ndidi Nwamu. “I urge patients to take the opportunity to come to our center, see what’s different, take a look around, meet our staff and discuss their healthcare goals.”

NxStage Kidney Care South Orlando provides a comfortable environment where patients have access to flexible in-center treatment options, peritoneal dialysis and home hemodialysis with the NxStage® System One™. Our staff works with patients and their doctors to develop treatment plans that are personalized to their individual lifestyles. Patients also have the opportunity to meet with the center’s renal social worker for guidance in the kidney transplant process.

NxStage Kidney Care South Orlando is located at 14522 Landstar Boulevard. For more information please call 407-454-5440 or visit

About NxStage Kidney Care

NxStage Kidney Care Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to support and encourage patient centered care and provide enhanced access to the life-changing benefits of home therapy as well as flexible in-center options. By leveraging NxStage's home leadership and the innovative technology of its System One, NxStage Kidney Care is committed to helping patients take control of their dialysis and to allowing physicians the flexibility to prescribe what is truly best for their patients. For more information, please visit or call 866-694-2707.

About Central Florida Kidney Center

Central Florida Kidney Centers, Inc., a nationally recognized provider of kidney care, has been serving patients with end stage renal disease for over forty-two years in Orange, Brevard, Osceola and Seminole counties. In addition to its long filled history of providing adult dialysis services, Central Florida Kidney Centers is the only out-patient dialysis center in Central Florida with an on-site Pediatric Nephrologist office that provides dialysis services to pediatric patients. For more information, please visit or call 800-253-2935.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “plan,” and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media contact:
Kristen K. Sheppard, Esq.
Tel: (978) 332-5923